{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:05:46Z","timestamp":1782770746515,"version":"3.54.5"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"crossref","award":["PSO-PHAC-2018-R8"],"award-info":[{"award-number":["PSO-PHAC-2018-R8"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To inform recommendations by the Canadian Task Force on Preventive Health Care by systematically reviewing direct evidence on the effectiveness and acceptability of screening adults 40\u2009years and older in primary care to reduce fragility fractures and related mortality and morbidity, and indirect evidence on the accuracy of fracture risk prediction tools. Evidence on the benefits and harms of pharmacological treatment will be reviewed, if needed to meaningfully influence the Task Force\u2019s decision-making.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A modified update of an existing systematic review will evaluate screening effectiveness, the accuracy of screening tools, and treatment benefits. For treatment harms, we will integrate studies from existing systematic reviews. A de novo review on acceptability will be conducted. Peer-reviewed searches (Medline, Embase, Cochrane Library, PsycINFO [acceptability only]), grey literature, and hand searches of reviews and included studies will update the literature. Based on pre-specified criteria, we will screen studies for inclusion following a liberal-accelerated approach. Final inclusion will be based on consensus. Data extraction for study results will be performed independently by two reviewers while other data will be verified by a second reviewer; there may be some reliance on extracted data from the existing reviews. The risk of bias assessments reported in the existing reviews will be verified and for new studies will be performed independently. When appropriate, results will be pooled using either pairwise random effects meta-analysis (screening and treatment) or restricted maximum likelihood estimation with Hartun-Knapp-Sidnick-Jonkman correction (risk prediction model calibration). Subgroups of interest to explain heterogeneity are age, sex, and menopausal status. Two independent reviewers will rate the certainty of evidence using the GRADE approach, with consensus reached for each outcome rated as critical or important by the Task Force.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Since the publication of other guidance in Canada, new trials have been published that are likely to improve understanding of screening in primary care settings to prevent fragility fractures. A systematic review is required to inform updated recommendations that align with the current evidence base.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13643-019-1094-5","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T08:02:53Z","timestamp":1566547373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Screening to prevent fragility fractures among adults 40 years and older in primary care: protocol for a systematic review"],"prefix":"10.1186","volume":"8","author":[{"given":"Michelle","family":"Gates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-7229","authenticated-orcid":false,"given":"Jennifer","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guyl\u00e8ne","family":"Th\u00e9riault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Grad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Klarenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Korownyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett D.","family":"Thombs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Courage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vandermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Featherstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Summary. CMAJ. 2010;182:1864\u201373.","journal-title":"CMAJ."},{"key":"1094_CR2","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00198-010-1445-5","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, et al. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int. 2011;22:1873\u201383.","journal-title":"Osteoporos Int."},{"key":"1094_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00198-010-1464-2","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, et al. Construction of a FRAX\u00ae model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int. 2011;22:817\u201327.","journal-title":"Osteoporos Int."},{"key":"1094_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2018","unstructured":"Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 2018;391:741\u20137.","journal-title":"Lancet."},{"key":"1094_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12891-017-1783-y","volume":"18","author":"PJM Elders","year":"2017","unstructured":"Elders PJM, Merlijn T, Swart KMA, van Hout W, van der Zwaard BC, Niemeijer C, et al. Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65\u2009years or older. BMC Musculoskel Disord. 2017;18:424.","journal-title":"BMC Musculoskel Disord."},{"key":"1094_CR6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"JA Kanis","year":"2002","unstructured":"Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929\u201336.","journal-title":"Lancet."},{"key":"1094_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1503\/cmaj.070234","volume":"177","author":"A Cranney","year":"2007","unstructured":"Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD. Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007;177:575\u201380.","journal-title":"CMAJ."},{"key":"1094_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s001980070050","volume":"11","author":"A Tenenhouse","year":"2000","unstructured":"Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2000;11:897\u2013904.","journal-title":"Osteoporos Int."},{"key":"1094_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11914-011-0060-5","volume":"9","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Schousboe JT. A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world. Curr Osteoporos Rep. 2011;9:129\u201340.","journal-title":"Curr Osteoporos Rep."},{"key":"1094_CR10","volume-title":"Osteoporosis: diagnosis, treatment, and fracture prevention","author":"British Columbia Medical Association, British Columbia Ministry of Health","year":"2012","unstructured":"British Columbia Medical Association, British Columbia Ministry of Health. Osteoporosis: diagnosis, treatment, and fracture prevention. 2012. https:\/\/www2.gov.bc.ca\/gov\/content\/health\/practitioner-professional-resources\/bc-guidelines\/osteoporosis. Accessed 31 Jan 2019."},{"key":"1094_CR11","first-page":"839","volume":"36","author":"A Khan","year":"2014","unstructured":"Khan A, Fortier M. Menopause and Osteoporosis Working Group. Osteoporosis in menopause. JOGC. 2014;36:839\u201340.","journal-title":"Osteoporosis in menopause. JOGC."},{"key":"1094_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.carj.2013.07.006","volume":"64","author":"K Siminoski","year":"2013","unstructured":"Siminoski K, O'Keeffe M, Brown JP, Burrell S, Coupland D, Dumont M, et al. Canadian Association of Radiologists technical standards for bone mineral densitometry reporting. Can Assoc Radiol J. 2013;64:281\u201394.","journal-title":"Can Assoc Radiol J."},{"key":"1094_CR13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00198-014-2661-1","volume":"25","author":"S Allin","year":"2014","unstructured":"Allin S, Munce S, Carlin L, Butt D, Tu K, Hawker G, et al. Fracture risk assessment after BMD examination: whose job is it, anyway? Osteoporos Int. 2014;25:1445\u201353.","journal-title":"Osteoporos Int."},{"key":"1094_CR14","first-page":"566","volume":"7","author":"JE Sale","year":"2015","unstructured":"Sale JE, Bogoch E, Meadows L, Gignac M, Frankel L, Inrig T, et al. Bone mineral density reporting underestimates fracture risk in Ontario. Health (Irvine Calif.). 2015;7:566\u201371.","journal-title":"Health (Irvine Calif.)."},{"key":"1094_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/BOR.0000000000000065","volume":"26","author":"SR Majumdar","year":"2014","unstructured":"Majumdar SR. Implementation research in osteoporosis: an update. Curr Opin Rheumatol. 2014;26:453\u20137.","journal-title":"Curr Opin Rheumatol."},{"key":"1094_CR16","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jbmr.1956","volume":"28","author":"KH Rubin","year":"2013","unstructured":"Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K. Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. JBMR. 2013;28:1701\u201317.","journal-title":"JBMR."},{"key":"1094_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.carj.2011.05.001","volume":"62","author":"B Lentle","year":"2011","unstructured":"Lentle B, Cheung AM, Hanley DA, Leslie WD, Lyons D, Papaioannou A, et al. Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J. 2011;62:243\u201350.","journal-title":"Can Assoc Radiol J."},{"key":"1094_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bone.2014.10.026","volume":"71","author":"JC Prior","year":"2015","unstructured":"Prior JC, Langsetmo L, Lentle BC, Berger C, Goltzman D, Kovacs CS, et al. Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study \u2014 comparing site and age-specific risks in women and men. Bone. 2015;71:237\u201343.","journal-title":"Bone."},{"key":"1094_CR19","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2018.6537","volume":"319","author":"M Viswanathan","year":"2018","unstructured":"Viswanathan M, Reddy S, Berkman N, et al. Screening to prevent osteoporotic fractures: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319:2532\u201351.","journal-title":"JAMA."},{"key":"1094_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1748-5908-5-80","volume":"5","author":"EA Little","year":"2010","unstructured":"Little EA, Eccles MP. A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implementation Sci. 2010;5:80.","journal-title":"Implementation Sci."},{"key":"1094_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00198-012-2090-y","volume":"24","author":"K Ganda","year":"2013","unstructured":"Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR, et al. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2013;24:393\u2013406.","journal-title":"Osteoporos Int."},{"key":"1094_CR22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00198-017-3986-3","volume":"28","author":"SR Majumdar","year":"2017","unstructured":"Majumdar SR, Lier DA, Hanley DA, Juby AG, Beaupre LA, for the Stop-Prihs Team. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the \u201cCatch a Break\u201d 1i [type C] FLS. Osteoporos Int. 2017;28:1965\u201377.","journal-title":"Osteoporos Int"},{"key":"1094_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cger.2014.01.001","volume":"30","author":"SM Friedman","year":"2014","unstructured":"Friedman SM, Mendelson DA. Epidemiology of fragility fractures. Clin Geriatr Med. 2014;30:175\u201381.","journal-title":"Clin Geriatr Med."},{"key":"1094_CR24","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1359\/jbmr.080515","volume":"23","author":"EV McCloskey","year":"2008","unstructured":"McCloskey EV, Vasireddy S, Threlkeld J, Eastaugh J, Parry A, Bonnet N, et al. Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis. JBMR. 2008;23:1561\u20138.","journal-title":"JBMR."},{"key":"1094_CR25","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/jbmr.2204","volume":"29","author":"SN Morin","year":"2014","unstructured":"Morin SN, Lix LM, Leslie WD. The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women. JBMR. 2014;29:1675\u201380.","journal-title":"JBMR."},{"key":"1094_CR26","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1001\/archinte.168.20.2261","volume":"168","author":"AB Hodsman","year":"2008","unstructured":"Hodsman AB, Leslie WD, Tsang JF, Gamble GD. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the manitoba bone density program. Arch Intern Med. 2008;168:2261\u20137.","journal-title":"Arch Intern Med."},{"issue":"nov19 1","key":"1094_CR27","doi-asserted-by":"publisher","first-page":"b4229","DOI":"10.1136\/bmj.b4229","volume":"339","author":"J. Hippisley-Cox","year":"2009","unstructured":"Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of Qfracture scores. BMJ. 2009;339.","journal-title":"BMJ"},{"issue":"20","key":"1094_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.298.20.2389","volume":"298","author":"J Robbins","year":"2007","unstructured":"Robbins J, Aragaki AK, Kooperberg C, et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA. 2007;298(20):2389\u201398.","journal-title":"JAMA."},{"key":"1094_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/BOR.0000000000000400","volume":"29","author":"BL Langdahl","year":"2017","unstructured":"Langdahl BL. Osteoporosis in premenopausal women. Curr Opin Rheumatol. 2017;29:410\u20135.","journal-title":"Curr Opin Rheumatol."},{"key":"1094_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ecl.2016.09.007","volume":"46","author":"A Cohen","year":"2017","unstructured":"Cohen A. Premenopausal osteoporosis. Endocrinol Metab Clin North Am. 2017;46:117\u201333.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"1094_CR31","unstructured":"World Health Organization. WHO Technical Report Series: assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva; 1994."},{"key":"1094_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18773\/austprescr.2016.020","volume":"39","author":"A Sheu","year":"2016","unstructured":"Sheu A, Diamond T. Secondary osteoporosis. Aust Prescr. 2016;39:85.","journal-title":"Aust Prescr."},{"key":"1094_CR33","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00198-016-3631-6","volume":"27","author":"RB Hopkins","year":"2016","unstructured":"Hopkins RB, Burke N, Von Keyserlingk C, Leslie WD, Morin SN, Adachi JD, et al. The current economic burden of illness of osteoporosis in Canada. Osteoporos Int. 2016;27:3023\u201332.","journal-title":"Osteoporos Int."},{"key":"1094_CR34","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00198-012-1931-z","volume":"23","author":"JE Tarride","year":"2012","unstructured":"Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, Papaioannou A, et al. The burden of illness of osteoporosis in Canada. Osteoporos Int. 2012;23:2591\u2013600.","journal-title":"Osteoporos Int."},{"key":"1094_CR35","volume-title":"Public Health Infobase: Canadian Chronic Disease Indicators","author":"Public Health Agency of Canada","year":"2018","unstructured":"Public Health Agency of Canada. Public Health Infobase: Canadian Chronic Disease Indicators. Ottawa: Public Health Agency of Canada; 2018."},{"key":"1094_CR36","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4065\/mcp.2010.0082","volume":"85","author":"JD Adachi","year":"2010","unstructured":"Adachi JD, Adami S, Gehlbach S, Anderson FA, Boonen S, Chapurlat RD, et al. Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. May Clin Proc. 2010;85:806\u201313.","journal-title":"May Clin Proc."},{"key":"1094_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1503\/cmaj.081720","volume":"181","author":"G Ioannidis","year":"2009","unstructured":"Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, et al. Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ. 2009;181:265\u201371.","journal-title":"CMAJ."},{"key":"1094_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00198-008-0743-7","volume":"20","author":"A Papaioannou","year":"2009","unstructured":"Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, et al. The impact of incident fractures on health-related quality of life: 5\u2009years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2009;20:703\u201314.","journal-title":"Osteoporos Int."},{"key":"1094_CR39","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s001980070066","volume":"11","author":"SA Jackson","year":"2000","unstructured":"Jackson SA, Tenenhouse A, Robertson L, and the CaMos Study Group. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int. 2000;11:680\u20137.","journal-title":"Osteoporos Int"},{"key":"1094_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocd.2015.08.004","volume":"19","author":"JT Schousboe","year":"2016","unstructured":"Schousboe JT. Epidemiology of vertebral fractures. J Clin Densitom. 2016;19:8\u201322.","journal-title":"J Clin Densitom."},{"key":"1094_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bone.2019.01.009","volume":"121","author":"JT Schousboe","year":"2019","unstructured":"Schousboe JT, Lix LM, Morin SN, Derkatch S, Bryanton M, Alhrbi M, et al. Prevalent vertebral fracture on bone density lateral spine (VFA) images in routine clinical practice predict incident fractures. Bone. 2019;121:72\u20139.","journal-title":"Bone."},{"key":"1094_CR42","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00586-011-1852-0","volume":"20","author":"V Puisto","year":"2011","unstructured":"Puisto V, Rissanen H, Heli\u00f6vaara M, Impivaara O, Jalanko T, Kr\u00f6ger H, et al. Vertebral fracture and cause-specific mortality: a prospective population study of 3210 men and 3730 women with 30 years of follow-up. Eur Spine J. 2011;20:2181\u20136.","journal-title":"Eur Spine J."},{"key":"1094_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00198-003-1516-y","volume":"15","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int. 2004;15:108\u201312.","journal-title":"Osteoporos Int."},{"key":"1094_CR44","first-page":"S125","volume":"26","author":"GG Teng","year":"2008","unstructured":"Teng GG. Curtis eR, Saag KG. Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol. 2008;26:S125\u2013S37.","journal-title":"Clin Exp Rheumatol."},{"key":"1094_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1759720X14564562","volume":"7","author":"TJ Aspray","year":"2015","unstructured":"Aspray TJ. Fragility fracture: recent developments in risk assessment. Ther Adv Musculoskelet Dis. 2015;7:17\u201325.","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"1094_CR46","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2018.7498","volume":"319","author":"United States Preventive Services Task Force","year":"2018","unstructured":"United States Preventive Services Task Force. Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement. JAMA. 2018;319:2521\u201331.","journal-title":"JAMA."},{"key":"1094_CR47","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1016\/j.jacr.2017.02.018","volume":"14","author":"RJ Ward","year":"2017","unstructured":"Ward RJ, Roberts CC, Bencardino JT, Arnold E, Baccei SJ, Cassidy RC, et al. ACR Appropriateness Criteria\u00ae osteoporosis and bone mineral density. J Am Coll Radiol. 2017;14:S189\u2013202.","journal-title":"J Am Coll Radiol."},{"key":"1094_CR48","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/AOG.0b013e31826dc45d","volume":"120","author":"The American College of Obstetricians and Gynecologists","year":"2012","unstructured":"The American College of Obstetricians and Gynecologists. ACOG practice bulletin N. 129. Osteoporosis. Obstet Gynecol. 2012;120:718\u201334.","journal-title":"Obstet Gynecol"},{"key":"1094_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23\u201357.","journal-title":"Osteoporos Int."},{"key":"1094_CR50","volume-title":"Osteoporosis: assessing the risk of fragility fracture","author":"National Clinical Guideline Centre","year":"2012","unstructured":"National Clinical Guideline Centre. Osteoporosis: assessing the risk of fragility fracture. London: National Institue for Health and Clinical Excellence (NICE); 2012."},{"key":"1094_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12:43.","journal-title":"Arch Osteoporos."},{"key":"1094_CR52","unstructured":"The International Society for Clinical Densitometry. ISCD official position: adults. 2015. https:\/\/www.iscd.org\/official-positions\/2015-iscd-official-positions-adult\/. Accessed 31 Jan 2019."},{"key":"1094_CR53","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:1802\u201322.","journal-title":"J Clin Endocrinol Metab."},{"key":"1094_CR54","unstructured":"Beithon J, Gallenberg M, Johnson K, Kildahl P, Krenik J, Liebow M, et al. Institute for Clinical Systems Improvement: diagnosis and treatment of osteoporosis. 2017. Available from: https:\/\/www.icsi.org\/guidelines__more\/catalog_guidelines_and_more\/catalog_guidelines\/catalog_womens_health_guidelines\/osteoporosis\/. Accessed 31 Jan 2019."},{"key":"1094_CR55","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:1595\u2013622.","journal-title":"J Clin Endocrinol Metab."},{"key":"1094_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV. A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11:25.","journal-title":"Arch Osteoporos"},{"key":"1094_CR57","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Od\u00e9n A, McCloskey EV, Johansson H, Wahl DA, Cooper C. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23:2239\u201356.","journal-title":"Osteoporos Int"},{"key":"1094_CR58","doi-asserted-by":"publisher","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","volume":"11","author":"KGM Moons","year":"2014","unstructured":"Moons KGM, de Groot JAH, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLOS Med. 2014;11:e1001744.","journal-title":"PLOS Med."},{"key":"1094_CR59","volume-title":"Management of osteoporosis and the prevention of fragility fractures. (SIGN publication no. 142)","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2015","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of osteoporosis and the prevention of fragility fractures. (SIGN publication no. 142). Edinburgh: SIGN; 2015."},{"key":"1094_CR60","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1359\/jbmr.061112","volume":"22","author":"WD Leslie","year":"2009","unstructured":"Leslie WD, Tsang JF, Caetano PA, Lix LM. Number of osteoporotic sites and fracture risk assessment: a cohort study from the Manitoba bone density program. JBMR. 2009;22:476\u201383.","journal-title":"JBMR."},{"key":"1094_CR61","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00198-005-0014-9","volume":"17","author":"JA Kanis","year":"2006","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, Eisman JA, Fujiwara S, et al. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int. 2006;17:527\u201334.","journal-title":"Osteoporos Int."},{"key":"1094_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jocd.2011.05.007","volume":"14","author":"DB Hans","year":"2011","unstructured":"Hans DB, Kanis JA, Baim S, Bilezikian JP, Binkley N, Cauley JA, et al. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R). Executive summary of the 2010 position development conference on interpretation and use of FRAX(R) in clinical practice. J Clin Densitom. 2011;14:171\u201380.","journal-title":"J Clin Densitom."},{"key":"1094_CR63","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00198-010-1461-5","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA. Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int. 2011;22:839\u201347.","journal-title":"Osteoporos Int."},{"issue":"3","key":"1094_CR64","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jocd.2011.04.011","volume":"14","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Kovacs CS, Olszynski WP, Towheed T, Kaiser SM, Prior JC, et al. Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX(R): a population-based report from CAMOS. J Clin Densitom. 2011;14(3):286\u201393.","journal-title":"J Clin Densitom."},{"key":"1094_CR65","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00223-014-9911-2","volume":"95","author":"H Johansson","year":"2014","unstructured":"Johansson H, Kanis JA, Oden A, Leslie WD, Fujiwara S, Gluer CC, et al. Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int. 2014;95:428\u201335.","journal-title":"Calcif Tissue Int."},{"key":"1094_CR66","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jbmr.3222","volume":"33","author":"BC Lentle","year":"2018","unstructured":"Lentle BC, Berger C, Probyn L, Brown JP, Langsetmo L, Fine B, et al. Comparative analysis of the radiology of osteoporotic vertebral fractures in women and men: cross-sectional and longitudinal observations from the Canadian Multicentre Osteoporosis Study (CaMos). J Bone Miner Res. 2018;33:569\u201379.","journal-title":"J Bone Miner Res."},{"key":"1094_CR67","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00198-004-1626-1","volume":"15","author":"G Jiang","year":"2004","unstructured":"Jiang G, Eastell R, Barrington NA, Ferrar L. Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int. 2004;15:887\u201396.","journal-title":"Osteoporos Int."},{"key":"1094_CR68","doi-asserted-by":"crossref","unstructured":"Griffith JF, Adams JE, Genant HK. Chapter 37: diagnosis and classification of vertebral fracture. In: Rosen C, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 8th ed: American Society for Bone and Mineral Research; 2013.","DOI":"10.1002\/9781118453926.ch37"},{"key":"1094_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.18773\/austprescr.2016.020","volume":"39","author":"A Sheu","year":"2016","unstructured":"Sheu A, Diamond T. Diagnostic tests: bone mineral density: testing for osteoporosis. Aust Prescr. 2016;39:35.","journal-title":"Aust Prescr."},{"key":"1094_CR70","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25:2359\u201381.","journal-title":"Osteoporos Int."},{"key":"1094_CR71","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00198-008-0559-5","volume":"19","author":"B Dawson-Hughes","year":"2008","unstructured":"Dawson-Hughes B, Tosteson ANA, Melton LJ, Baim S, Favus MJ, Khosla S, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008;19:449\u201358.","journal-title":"Osteoporos Int."},{"key":"1094_CR72","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"ANA Tosteson","year":"2008","unstructured":"Tosteson ANA, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19:437\u201347.","journal-title":"Osteoporos Int."},{"key":"1094_CR73","first-page":"178","volume":"56","author":"K Siminoski","year":"2005","unstructured":"Siminoski K, Leslie WD, Frame H, Hodsman A, Josse RG, Khan A, et al. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J. 2005;56:178\u201388.","journal-title":"Can Assoc Radiol J."},{"key":"1094_CR74","volume-title":"Osteoporose. Knochenbruch- Krankheit","author":"A Vernunft","year":"2010","unstructured":"Vernunft A. Osteoporose. Knochenbruch- Krankheit. \u00d6sterreichs: Pharmig, Verband der pharmazeutischen Industrie; 2010."},{"key":"1094_CR75","first-page":"38","volume":"12","author":"P Makras","year":"2012","unstructured":"Makras P, Vaiopoulos G, Lyritis GP. 2011 guidelines for the diagnosis and treatment of osteoporosis in Greece. J Musculoskelet Neuronal Interact. 2012;12:38\u201342.","journal-title":"J Musculoskelet Neuronal Interact."},{"key":"1094_CR76","first-page":"28","volume":"1","author":"P Lakatos","year":"2011","unstructured":"Lakatos P, Szekeres L, Takacs I, et al. Diagnostic and therapeutic guidelines for the age-related and glucocorticoid-induced osteoporosis \u20132011, Hungary. Magyar Reumatol\u00f3gia. 2011;1 Hungarian:28\u201333.","journal-title":"Magyar Reumatol\u00f3gia"},{"key":"1094_CR77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/1756-185x.12037","volume":"16","author":"SS Yeap","year":"2013","unstructured":"Yeap SS, Hew FL, Lee JK, Goh EM, Chee W, Mumtaz M, et al. The Malaysian Clinical Guidance on the management of postmenopausal osteoporosis, 2012: a summary. Int J Rheum Dis. 2013;16:30\u201340.","journal-title":"Int J Rheum Dis."},{"key":"1094_CR78","unstructured":"Malaysian Osteoporosis Society. Clinical guidance on management of osteoporosis. 2012. http:\/\/www.iofbonehealth.org\/sites\/default\/files\/PDFs\/National%20Guidelines\/Malaysia_CG_Mgmt_Osteoporosis_2012-0912-final.pdf. Accessed 31 Jan 2019."},{"key":"1094_CR79","unstructured":"Cymet-Ramirez J, Cisneros-Dreinhofer FA, Alvarez-Martinez MM, Cruz-Gonzalez I, de la Fuente-Zuno JC, Figueroa-Cal y Mayor FJ, et al. [Diagnosis and treatment of osteoporosis. Position of the Mexican College of Orthopedics and Traumatology]. Acta Ortop Mex. 2011;25:303-312."},{"key":"1094_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1756-185X.2011.01626.x","volume":"14","author":"J Li-Yu","year":"2011","unstructured":"Li-Yu J, Perez EC, Canete A, Bonifacio L, Llamado LQ, Martinez R, et al. Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines. Int J Rheum Dis. 2011;14:223\u201338.","journal-title":"Int J Rheum Dis."},{"key":"1094_CR81","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11657-013-0118-3","volume":"8","author":"TT Amin","year":"2013","unstructured":"Amin TT, Al Owaifeer A, Al-Hashim H, Alwosaifer A, Alabdulqader M, Al Hulaibi F, et al. Osteoporosis among older Saudis: Risk of fractures and unmet needs. Arch Osteoporos. 2013;8:118.","journal-title":"Arch Osteoporos."},{"key":"1094_CR82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.20452\/pamw.2255","volume":"124","author":"P Gluszko","year":"2014","unstructured":"Gluszko P, Lorenc RS, Karczmarewicz E, Misiorowski W, Jaworski M. Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update. Pol Arch Med Wewn. 2014;124:255\u201363.","journal-title":"Pol Arch Med Wewn"},{"key":"1094_CR83","first-page":"571","volume":"8","author":"E N\u00e9methov\u00e1","year":"2013","unstructured":"N\u00e9methov\u00e1 E, Killinger Z, Payer J. Fracture risk prediction with FRAX in Slovak postmenopausal women. Cent Eur J Med. 2013;8:571\u20136.","journal-title":"Cent Eur J Med."},{"key":"1094_CR84","unstructured":"Toma\u017e K, Janez P, Marija P, Mojca JS, Jensterle \u010cM, Andrej Z. Guidelines for the detection and treatment of osteoporosis. Slov Med J. 2013;84."},{"key":"1094_CR85","first-page":"357","volume":"7","author":"L Perez Edo","year":"2011","unstructured":"Perez Edo L, Alonso Ruiz A, Roig Vilaseca D, Garcia Vadillo A, Guanabens Gay N, Peris P, et al. 2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis. Rheumatol Clin. 2011;7:357\u201379.","journal-title":"Rheumatol Clin."},{"key":"1094_CR86","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.recot.2015.05.007","volume":"59","author":"I Etxebarria-Foronda","year":"2015","unstructured":"Etxebarria-Foronda I, Caeiro-Rey JR, Larrainzar-Garijo R, Vaquero-Cervino E, Roca-Ruiz L, Mesa-Ramos M, et al. SECOT-GEIOS guidelines in osteoporosis and fragility fracture. An update. Revista Espanola de Cirugia Ortopedica y Traumatologia. 2015;59:373\u201393.","journal-title":"Revista Espanola de Cirugia Ortopedica y Traumatologia."},{"key":"1094_CR87","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.endonu.2012.01.002","volume":"59","author":"R Reyes Garcia","year":"2012","unstructured":"Reyes Garcia R, Jodar Gimeno E, Garcia Martin A, Romero Munoz M, Gomez Saez JM, Luque Fernandez I, et al. Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Bone Metabolism Working Group of the Spanish Society of Endocrinology. Endocrinologia y Nutricion. 2012;59:174\u201396.","journal-title":"Endocrinologia y Nutricion."},{"key":"1094_CR88","unstructured":"Taiwanese Osteoporosis Association. Taiwanese guidelines for the prevention and treatment of osteoporosis. 2012. http:\/\/www.iofbonehealth.org\/sites\/default\/files\/PDFs\/National%20Guidelines\/Taiwanese_guidelines_prevention_treatment_osteoporosis.pdf. Accessed 31 Jan 2019."},{"key":"1094_CR89","first-page":"1528","volume":"95","author":"C Pongchaiyakul","year":"2012","unstructured":"Pongchaiyakul C, Leerapun T, Wongsiri S, Songpattanasilp T, Taechakraichana N. Value and validation of RCOST and TOPF clinical practice guideline for osteoporosis treatment. J Med Assoc Thai. 2012;95:1528\u201335.","journal-title":"J Med Assoc Thai."},{"key":"1094_CR90","volume-title":"Lebanese FRAX-Based Osteoporosis Guidelines","author":"M Chakhtoura","year":"2013","unstructured":"Chakhtoura M, Baddoura R, El-Hajj Fuleihan G. Lebanese FRAX-Based Osteoporosis Guidelines. 2013. http:\/\/www.osteos.org.lb\/admin\/uploads\/Full%20document.pdf. Accessed 31 Jan 2019."},{"key":"1094_CR91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3\u201344.","journal-title":"Osteoporos Int."},{"key":"1094_CR92","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11926-015-0533-0","volume":"17","author":"M Hiligsmann","year":"2015","unstructured":"Hiligsmann M, Bours SPG, Boonen A. A review of patient preferences for osteoporosis drug treatment. Curr Rheumatol Rep. 2015;17:61.","journal-title":"Curr Rheumatol Rep."},{"key":"1094_CR93","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s00198-013-2326-5","volume":"24","author":"K Reynolds","year":"2013","unstructured":"Reynolds K, Muntner P, Cheetham TC, Harrison TN, Morisky DE, Silverman S, et al. Primary non-adherence to bisphosphonates in an integrated healthcare setting. Osteoporos Int. 2013;24:2509\u201317.","journal-title":"Osteoporos Int."},{"key":"1094_CR94","volume-title":"Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 Report","author":"CJ Crandall","year":"2012","unstructured":"Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Suttorp MJ, et al. Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 Report. Agency for Healthcare Research and Quality: Rockville; 2012."},{"key":"1094_CR95","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3899\/jrheum.130548","volume":"41","author":"JM Neuner","year":"2014","unstructured":"Neuner JM, Schapira MM. Patient perceptions of osteoporosis treatment thresholds. J Rheumatol. 2014;41:516\u201322.","journal-title":"J Rheumatol."},{"key":"1094_CR96","volume-title":"Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: background and technical report","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin SN, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: background and technical report. 2010. https:\/\/osteoporosis.ca\/health-care-professionals\/clinical-practice-guidelines\/osteoporosis-guidelines\/. Accessed 31 Jan 2019."},{"key":"1094_CR97","volume-title":"Recalls and safety alerts: Synthetic calcitonin (salmon) nasal spray (NS) - market withdrawal of all products","author":"H Canada","year":"2013","unstructured":"Health Canada. Recalls and safety alerts: Synthetic calcitonin (salmon) nasal spray (NS) - market withdrawal of all products. 2013. http:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2013\/34783a-eng.php. Accessed 31 Jan 2019."},{"key":"1094_CR98","doi-asserted-by":"crossref","unstructured":"Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, et al. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008:CD003376.","DOI":"10.1002\/14651858.CD003376.pub3"},{"key":"1094_CR99","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7326\/M15-1361","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Forciea M, McLean RM, Denberg TD. for the Clinical Guidelines Committee of the American College of Physicians. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the american college of physicians. Ann Intern Med. 2017;166:818\u201339.","journal-title":"Ann Intern Med."},{"key":"1094_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161435.GL","volume":"22 Suppl 4","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, et al. American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016. Endocr Pract. 2016;22 Suppl 4:1\u201342.","journal-title":"Endocr Pract."},{"key":"1094_CR101","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1001\/jama.2017.18261","volume":"318","author":"DC Grossman","year":"2017","unstructured":"Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US Preventive Services Task Force recommendation statement. JAMA. 2017;318:2224\u201333.","journal-title":"JAMA."},{"key":"1094_CR102","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077\u201382.","journal-title":"JAMA."},{"key":"1094_CR103","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","volume":"367","author":"S Boonen","year":"2012","unstructured":"Boonen S, Reginster J-Y, Kaufman J-M, Lippuner K, Zanchetta J, Langdahl B, et al. Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med. 2012;367:1714\u201323.","journal-title":"N Engl J Med."},{"key":"1094_CR104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0969-8043(98)00026-8","volume":"50","author":"CF Njeh","year":"1999","unstructured":"Njeh CF, Fuerst T, Hans D, Blake GM, Genant HK. Radiation exposure in bone mineral density assessment. Appl Radiat Isot. 1999;50:215\u201336.","journal-title":"Appl Radiat Isot."},{"key":"1094_CR105","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11657-016-0286-z","volume":"11","author":"KL Barker","year":"2016","unstructured":"Barker KL, Toye F, Lowe CJM. A qualitative systematic review of patients\u2019 experience of osteoporosis using meta-ethnography. Arch Osteoporos. 2016;11:33.","journal-title":"Arch Osteoporos."},{"key":"1094_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7915041","volume":"2016","author":"A. E. Bombak","year":"2016","unstructured":"Bombak A, Hanson H. Qualitative insights from the osteoporosis research: a narrative review of the literature. J Osteoporos. 2016;2016 https:\/\/doi.org\/10.1155\/2016\/7915041.","journal-title":"Journal of Osteoporosis"},{"key":"1094_CR107","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12905-017-0377-z","volume":"17","author":"CA Hansen","year":"2017","unstructured":"Hansen CA, Abrahamsen B, Konradsen H, Pedersen BD. Women\u2019s lived experiences of learning to live with osteoporosis: a longitudinal qualitative study. BMC Womens Health. 2017;17:17.","journal-title":"BMC Womens Health."},{"key":"1094_CR108","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/j.socscimed.2005.11.009","volume":"62","author":"SD Reventlow","year":"2006","unstructured":"Reventlow SD, Hvas L, Malterud K. Making the invisible body visible. Bone scans, osteoporosis and women's bodily experiences. Soc Sci Med. 2006;62:2720\u201331.","journal-title":"Soc Sci Med."},{"key":"1094_CR109","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00198-016-3693-5","volume":"28","author":"LA Wozniak","year":"2017","unstructured":"Wozniak LA, Johnson JA, McAlister FA, Beaupre LA, Bellerose D, Rowe BH, et al. Understanding fragility fracture patients\u2019 decision-making process regarding bisphosphonate treatment. Osteoporos Int. 2017;28:219\u201329.","journal-title":"Osteoporos Int."},{"key":"1094_CR110","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2017.01.024","volume":"104","author":"EM Curtis","year":"2017","unstructured":"Curtis EM, Moon RJ, Harvey NC, Cooper C. The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone. 2017;104:29\u201338.","journal-title":"Bone."},{"key":"1094_CR111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","volume":"105","author":"E Tsourdi","year":"2017","unstructured":"Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guanabens N, et al. Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone. 2017;105:11\u20137.","journal-title":"Bone."},{"key":"1094_CR112","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M, et al. Vertebral fractures after discontinuation of Denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. 2018;33:190\u20138.","journal-title":"J Bone Miner Res."},{"key":"1094_CR113","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00198-017-4242-6","volume":"29","author":"MB Zanchetta","year":"2018","unstructured":"Zanchetta MB, Boailchuk J, Massari F, Silveira F, Bogado C, Zanchetta JR. Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study. Osteoporos Int. 2018;29:41\u20137.","journal-title":"Osteoporos Int."},{"key":"1094_CR114","unstructured":"Canadian Task Force on Preventive Health Care. Procedure Manual. 2014. https:\/\/canadiantaskforce.ca\/methods\/. Accessed 31 Jan 2019."},{"key":"1094_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev."},{"key":"1094_CR116","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Med. 2009;6:e1000100.","journal-title":"PLOS Med."},{"key":"1094_CR117","unstructured":"Government of Canada. About primary health care. 2012. https:\/\/www.canada.ca\/en\/health-canada\/services\/primary-health-care\/about-primary-health-care.html. Accessed 31 Jan 2019."},{"key":"1094_CR118","unstructured":"International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Clinical safety data management: Definitions and standards for expedited reportings e2a. 1994. https:\/\/www.ich.org\/products\/guidelines\/efficacy\/efficacy-single\/article\/clinical-safety-data-management-definitions-and-standards-for-expedited-reporting.html. Accessed 31 Jan 2019"},{"key":"1094_CR119","unstructured":"United Nations Development Programme (UNDP). Human development report. Human development for everyone. 2016:2016 http:\/\/hdr.undp.org\/sites\/default\/files\/2016_human_development_report.pdf. Accessed 31 Jan 2019."},{"key":"1094_CR120","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jclinepi.2015.05.035","volume":"70","author":"KA Robinson","year":"2016","unstructured":"Robinson KA, Chou R, Berkman ND, Newberry SJ, Fu R, Hartling L, et al. Twelve recommendations for integrating existing systematic reviews into new reviews: EPC guidance. J Clin Epidemiol. 2016;70:38\u201344.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR121","doi-asserted-by":"publisher","first-page":"711","DOI":"10.7326\/M14-0317","volume":"161","author":"CJ Crandall","year":"2014","unstructured":"Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, et al. Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med. 2014;161:711\u201323.","journal-title":"Ann Intern Med."},{"key":"1094_CR122","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR123","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","volume":"28","author":"A Morrison","year":"2012","unstructured":"Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of english-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28:138\u201344.","journal-title":"Int J Technol Assess Health Care."},{"key":"1094_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7410","volume":"7","author":"D Moher","year":"2003","unstructured":"Moher D, Pham B, Lawson ML, Klassen TP. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess. 2003;7:1\u201390.","journal-title":"Health Technol Assess."},{"key":"1094_CR125","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2046-4053-1-10","volume":"1","author":"S Khangura","year":"2012","unstructured":"Khangura S, Konnyu K, Cushman R, Grimshaw J, Moher D. Evidence summaries: the evolution of a rapid review approach. Syst Rev. 2012;1:10.","journal-title":"Syst Rev."},{"key":"1094_CR126","unstructured":"O'Blenis P. One simple way to speed up your screening process. Evidence Partners; 2017. https:\/\/blog.evidencepartners.com\/one-simple-way-to-speed-up-your-screening-process. Accessed 12 June 2019."},{"key":"1094_CR127","unstructured":"SourceForge. Plot Digitizer Software. 2018. http:\/\/plotdigitizer.sourceforge.net\/. Accessed 31 Jan 2019."},{"key":"1094_CR128","doi-asserted-by":"crossref","unstructured":"Debray TPA, Damen JAAG, Snell KIE, Ensor J, Hooft L, Reitsma JB, et al. A guide to systematic review and meta-analysis of prediction model performance. BMJ. 2017;356.","DOI":"10.1136\/bmj.i6460"},{"issue":"oct18 2","key":"1094_CR129","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"J. P. T. Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343.","journal-title":"BMJ"},{"key":"1094_CR130","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","volume":"170","author":"KM Moons","year":"2019","unstructured":"Moons KM, Wolff RF, Riley RD, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170:W1\u2013W33.","journal-title":"Ann Intern Med."},{"key":"1094_CR131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KM, Riley RD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170:51\u20138.","journal-title":"Ann Intern Med."},{"key":"1094_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled clinical trials. 1996;17:1\u201312.","journal-title":"Controlled clinical trials."},{"key":"1094_CR133","volume-title":"Green S (editors). Cochrane handbook for systematic reviews of interventions, version 5.1.0","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT. Green S (editors). Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration: London; 2011."},{"key":"1094_CR134","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA Wells","year":"2009","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2009. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 31 Jan 2019."},{"key":"1094_CR135","unstructured":"National Institute of Health, National Heart, Lung, and Blood Institute. Study quality assessment tools: Quality assessment tool for observational cohort and cross-sectional studies. National Institue of Health; 2019. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Accessed 12 June 2019."},{"key":"1094_CR136","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986;7:177\u201388.","journal-title":"Controlled clinical trials."},{"key":"1094_CR137","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","volume":"27","author":"S Yusuf","year":"1985","unstructured":"Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335\u201371.","journal-title":"Prog Cardiovasc Dis."},{"key":"1094_CR138","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA, Russell LA. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Statistics in Medicine. 2007;26:53\u201377.","journal-title":"Statistics in Medicine."},{"key":"1094_CR139","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7326\/M13-2886","volume":"160","author":"JE Cornell","year":"2014","unstructured":"Cornell JE, Mulrow CD, Localio R, Stack CB, Meibohm AR, Guallar E, et al. Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med. 2014;160:267\u201370.","journal-title":"Ann Intern Med."},{"key":"1094_CR140","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14:25.","journal-title":"BMC Med Res Methodol."},{"key":"1094_CR141","volume-title":"Development and application of statistical methods for prognosis research","author":"KIE Snell","year":"2015","unstructured":"Snell KIE. Development and application of statistical methods for prognosis research. Birmingham: University of Birmingham; 2015."},{"key":"1094_CR142","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-14-5","volume":"14","author":"D van Klaveren","year":"2014","unstructured":"van Klaveren D, Steyerberg EW, Perel P, Vergouwe Y. Assessing discriminative ability of risk models in clustered data. BMC Med Res Methodol. 2014;14:5.","journal-title":"BMC Med Res Methodol."},{"key":"1094_CR143","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/0962280207087173","volume":"17","author":"G Qin","year":"2008","unstructured":"Qin G, Hotilovac L. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test. Stat Methods Med Res. 2008;17:207\u201321.","journal-title":"Stat Methods Med Res."},{"key":"1094_CR144","volume-title":"Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme","author":"J Popay","year":"2006","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Ridgers M. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. 2006. http:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.178.3100&rep=rep1&type=pdf. Accessed 12 June 2019."},{"key":"1094_CR145","volume-title":"Handling continuous outcomes in quantitative synthesis","author":"R Fu","year":"2013","unstructured":"Fu R, Vandermeer BW, Shamliyan TA, O\u2019Neil ME, Yazdi F, Fox SH, et al. Handling continuous outcomes in quantitative synthesis. Agency for Healthcare Research and Quality: Rockville; 2013."},{"key":"1094_CR146","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jclinepi.2005.08.017","volume":"59","author":"N Wiebe","year":"2006","unstructured":"Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ. A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol. 2006;59:342\u201353.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR147","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12874-018-0483-0","volume":"18","author":"CJ Weir","year":"2018","unstructured":"Weir CJ, Butcher I, Assi V, Lewis SC, Murray GD, Langhorne P, et al. Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review. BMC Med Res Methodol. 2018;18:25.","journal-title":"BMC Med Res Methodol."},{"issue":"1","key":"1094_CR148","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","volume":"59","author":"TA Furukawa","year":"2006","unstructured":"Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59(1):7\u201310.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR149","doi-asserted-by":"publisher","first-page":"d2304","DOI":"10.1136\/bmj.d2304","volume":"343","author":"DG Altman","year":"2011","unstructured":"Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343:d2304.","journal-title":"BMJ."},{"key":"1094_CR150","doi-asserted-by":"publisher","first-page":"d2090","DOI":"10.1136\/bmj.d2090","volume":"343","author":"DG Altman","year":"2011","unstructured":"Altman DG, Bland JM. How to obtain the confidence interval from a P value. BMJ. 2011;343:d2090.","journal-title":"BMJ."},{"key":"1094_CR151","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","volume":"116","author":"AD Oxman","year":"1992","unstructured":"Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78\u201384.","journal-title":"Ann Intern Med."},{"issue":"2","key":"1094_CR152","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cegh.2018.05.005","volume":"7","author":"Marty Richardson","year":"2019","unstructured":"Richardson M, Garner P, Donegan S. Interpretation of subgroup analyses in systematic reviews: a tutorial. Clin Epidemiol Glob Health. 2018. https:\/\/doi.org\/10.1016\/j.cegh.2018.05.005.","journal-title":"Clinical Epidemiology and Global Health"},{"issue":"feb10 2","key":"1094_CR153","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","volume":"342","author":"R. D. Riley","year":"2011","unstructured":"Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342.","journal-title":"BMJ"},{"key":"1094_CR154","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ."},{"key":"1094_CR155","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jrsm.1266","volume":"9","author":"TP Debray","year":"2018","unstructured":"Debray TP, Moons KG, Riley RD. Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: a comparison of new and existing tests. Res Synth Methods. 2018;9:41\u201350.","journal-title":"Res Synth Methods."},{"key":"1094_CR156","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","volume":"87","author":"M Hultcrantz","year":"2017","unstructured":"Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4\u201313.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR157","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence\u2014imprecision. J Clin Epidemiol. 2011;64:1283\u201393.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR158","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness. J Clin Epidemiol. 2011;64:1303\u201310.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR159","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol. 2011;64:1294\u2013302.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR160","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence\u2014publication bias. J Clin Epidemiol. 2011;64:1277\u201382.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR161","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias). J Clin Epidemiol. 2011;64:407\u201315.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR162","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ."},{"key":"1094_CR163","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles\u2014continuous outcomes. J Clin Epidemiol. 2013;66:173\u201383.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR164","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. GRADE guidelines: 12. Preparing Summary of Findings tables\u2014binary outcomes. J Clin Epidemiol. 2013;66:158\u201372.","journal-title":"J Clin Epidemiol."},{"key":"1094_CR165","unstructured":"Evidence Prime. GRADEpro GDT. Hamilton, ON; 2019. https:\/\/www.gradepro.org. Accessed 31 Jan 2019."},{"key":"1094_CR166","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","volume":"66","author":"J Andrews","year":"2013","unstructured":"Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719\u201325.","journal-title":"J Clin Epidemiol."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-019-1094-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T12:45:11Z","timestamp":1721652311000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-019-1094-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":166,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1186\/s13643-019-1094-5","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}